Published in Genome Res on June 10, 2014
Tumour hypoxia causes DNA hypermethylation by reducing TET activity. Nature (2016) 1.67
EMT and tumor metastasis. Clin Transl Med (2015) 1.29
Role of TET enzymes in DNA methylation, development, and cancer. Genes Dev (2016) 1.08
Whole-genome fingerprint of the DNA methylome during human B cell differentiation. Nat Genet (2015) 1.07
Whole-epigenome analysis in multiple myeloma reveals DNA hypermethylation of B cell-specific enhancers. Genome Res (2015) 0.96
The role of DNA methylation in directing the functional organization of the cancer epigenome. Genome Res (2015) 0.94
Epigenomic analysis detects aberrant super-enhancer DNA methylation in human cancer. Genome Biol (2016) 0.92
Bivalent Regions of Cytosine Methylation and H3K27 Acetylation Suggest an Active Role for DNA Methylation at Enhancers. Mol Cell (2016) 0.91
Post-conversion targeted capture of modified cytosines in mammalian and plant genomes. Nucleic Acids Res (2015) 0.89
Three-dimensional disorganization of the cancer genome occurs coincident with long-range genetic and epigenetic alterations. Genome Res (2016) 0.88
Genome-wide assays that identify and quantify modified cytosines in human disease studies. Epigenetics Chromatin (2015) 0.88
DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancer. Nat Commun (2015) 0.86
Roles of Distal and Genic Methylation in the Development of Prostate Tumorigenesis Revealed by Genome-wide DNA Methylation Analysis. Sci Rep (2016) 0.82
Subtelomeric p53 binding prevents accumulation of DNA damage at human telomeres. EMBO J (2015) 0.81
Enhancer alterations in cancer: a source for a cell identity crisis. Genome Med (2014) 0.80
Noncoding somatic and inherited single-nucleotide variants converge to promote ESR1 expression in breast cancer. Nat Genet (2016) 0.79
Comprehensively evaluating cis-regulatory variation in the human prostate transcriptome by using gene-level allele-specific expression. Am J Hum Genet (2015) 0.79
Altered promoter nucleosome positioning is an early event in gene silencing. Epigenetics (2014) 0.79
Enhancer methylation dynamics contribute to cancer plasticity and patient mortality. Genome Res (2016) 0.79
Protection of CpG islands from DNA methylation is DNA-encoded and evolutionarily conserved. Nucleic Acids Res (2016) 0.79
Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits. Epigenetics Chromatin (2016) 0.79
Identification of chromatin accessibility domains in human breast cancer stem cells. Nucleus (2016) 0.78
Tissue-specific epigenetics in gene neighborhoods: myogenic transcription factor genes. Hum Mol Genet (2015) 0.78
Identification of candidate genes for prostate cancer-risk SNPs utilizing a normal prostate tissue eQTL data set. Nat Commun (2015) 0.78
Whole genome DNA methylation: beyond genes silencing. Oncotarget (2016) 0.78
Methylome-wide Sequencing Detects DNA Hypermethylation Distinguishing Indolent from Aggressive Prostate Cancer. Cell Rep (2015) 0.77
Overlapping DNA methylation dynamics in mouse intestinal cell differentiation and early stages of malignant progression. PLoS One (2015) 0.77
p53 binding to human genome: crowd control navigation in chromatin context. Front Genet (2014) 0.77
Nucleosomes are enriched at the boundaries of hypomethylated regions (HMRs) in mouse dermal fibroblasts and keratinocytes. Epigenetics Chromatin (2014) 0.77
Hierarchical clustering of breast cancer methylomes revealed differentially methylated and expressed breast cancer genes. PLoS One (2015) 0.77
Genome-wide nucleosome occupancy and DNA methylation profiling of four human cell lines. Genom Data (2014) 0.76
Chromatin remodeling during in vivo neural stem cells differentiating to neurons in early Drosophila embryos. Cell Death Differ (2016) 0.76
Enhancer deregulation in cancer and other diseases. Bioessays (2016) 0.76
Pre-neoplastic epigenetic disruption of transcriptional enhancers in chronic inflammation. Oncotarget (2016) 0.75
DNA methylation and chromatin accessibility profiling of mouse and human fetal germ cells. Cell Res (2016) 0.75
Incorporating Functional Annotations for Fine-Mapping Causal Variants in a Bayesian Framework Using Summary Statistics. Genetics (2016) 0.75
Small genomic insertions form enhancers that misregulate oncogenes. Nat Commun (2017) 0.75
DNA methylation analysis of paediatric low-grade astrocytomas identifies a tumour-specific hypomethylation signature in pilocytic astrocytomas. Acta Neuropathol Commun (2016) 0.75
Nucleosome positioning is unaltered at MLH1 splice site mutations in cells derived from Lynch syndrome patients. Clin Epigenetics (2014) 0.75
Embryonic Stem Cell (ES)-Specific Enhancers Specify the Expression Potential of ES Genes in Cancer. PLoS Genet (2016) 0.75
epiG: statistical inference and profiling of DNA methylation from whole-genome bisulfite sequencing data. Genome Biol (2017) 0.75
Variant Set Enrichment: an R package to identify disease-associated functional genomic regions. BioData Min (2017) 0.75
Nucleosome-free DNA regions differentially affect distant communication in chromatin. Nucleic Acids Res (2016) 0.75
The dynamic DNA methylation landscape of the mutL homolog 1 shore is altered by MLH1-93G>A polymorphism in normal tissues and colorectal cancer. Clin Epigenetics (2017) 0.75
A pre-neoplastic epigenetic field defect in HCV-infected liver at transcription factor binding sites and polycomb targets. Oncogene (2016) 0.75
Characterizing Genetic Susceptibility to Breast Cancer in Women of African Ancestry. Cancer Epidemiol Biomarkers Prev (2017) 0.75
Identification of cis-regulatory mutations generating de novo edges in personalized cancer gene regulatory networks. Genome Med (2017) 0.75
Chromatin-state discovery and genome annotation with ChromHMM. Nat Protoc (2017) 0.75
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol (2009) 235.12
High-resolution profiling of histone methylations in the human genome. Cell (2007) 85.74
The epigenomics of cancer. Cell (2007) 30.91
Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature (2009) 24.41
Mapping and analysis of chromatin state dynamics in nine human cell types. Nature (2011) 24.37
Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell (2010) 23.97
The accessible chromatin landscape of the human genome. Nature (2012) 16.86
Dynamic regulation of nucleosome positioning in the human genome. Cell (2008) 15.60
A genomic code for nucleosome positioning. Nature (2006) 15.38
Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet (2012) 15.21
Genome-scale identification of nucleosome positions in S. cerevisiae. Science (2005) 15.04
A high-resolution atlas of nucleosome occupancy in yeast. Nat Genet (2007) 12.21
The DNA-encoded nucleosome organization of a eukaryotic genome. Nature (2008) 11.41
A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer (2011) 11.33
Discovery and characterization of chromatin states for systematic annotation of the human genome. Nat Biotechnol (2010) 9.84
DNA-binding factors shape the mouse methylome at distal regulatory regions. Nature (2011) 8.75
A high-resolution, nucleosome position map of C. elegans reveals a lack of universal sequence-dictated positioning. Genome Res (2008) 7.77
FAIRE (Formaldehyde-Assisted Isolation of Regulatory Elements) isolates active regulatory elements from human chromatin. Genome Res (2006) 7.72
ChromHMM: automating chromatin-state discovery and characterization. Nat Methods (2012) 7.66
An expansive human regulatory lexicon encoded in transcription factor footprints. Nature (2012) 7.27
Chromatin accessibility pre-determines glucocorticoid receptor binding patterns. Nat Genet (2011) 6.98
Chromatin remodelling at promoters suppresses antisense transcription. Nature (2007) 6.11
Dynamic remodeling of individual nucleosomes across a eukaryotic genome in response to transcriptional perturbation. PLoS Biol (2008) 5.88
Nucleosome positions predicted through comparative genomics. Nat Genet (2006) 5.81
Association of Myn, the murine homolog of max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation. Cell (1991) 5.76
Distinct modes of regulation by chromatin encoded through nucleosome positioning signals. PLoS Comput Biol (2008) 5.71
Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina-associated domains. Nat Genet (2011) 5.70
Global nucleosome occupancy in yeast. Genome Biol (2004) 5.49
Sequence features and chromatin structure around the genomic regions bound by 119 human transcription factors. Genome Res (2012) 4.80
Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region. Science (1991) 4.45
Open chromatin defined by DNaseI and FAIRE identifies regulatory elements that shape cell-type identity. Genome Res (2011) 4.43
Characterizing and measuring bias in sequence data. Genome Biol (2013) 4.39
Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line. Proc Natl Acad Sci U S A (2008) 4.20
Role of nucleosomal occupancy in the epigenetic silencing of the MLH1 CpG island. Cancer Cell (2007) 3.15
Cell cycle-specified fluctuation of nucleosome occupancy at gene promoters. PLoS Genet (2006) 3.08
A functional evolutionary approach to identify determinants of nucleosome positioning: a unifying model for establishing the genome-wide pattern. Mol Cell (2012) 2.86
Determinants of nucleosome positioning. Nat Struct Mol Biol (2013) 2.47
Widespread plasticity in CTCF occupancy linked to DNA methylation. Genome Res (2012) 2.45
Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity. Nat Cell Biol (2010) 2.38
Selective anchoring of DNA methyltransferases 3A and 3B to nucleosomes containing methylated DNA. Mol Cell Biol (2009) 2.34
Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer. PLoS Genet (2010) 2.27
Gene expression divergence in yeast is coupled to evolution of DNA-encoded nucleosome organization. Nat Genet (2009) 2.22
The gateway to transcription: identifying, characterizing and understanding promoters in the eukaryotic genome. Cell Mol Life Sci (2007) 2.20
Epigenomic enhancer profiling defines a signature of colon cancer. Science (2012) 2.15
Polycomb-repressed genes have permissive enhancers that initiate reprogramming. Cell (2011) 2.14
Genome-wide mapping of nucleosome positioning and DNA methylation within individual DNA molecules. Genome Res (2012) 1.95
Regional activation of the cancer genome by long-range epigenetic remodeling. Cancer Cell (2012) 1.91
H2A.Z maintenance during mitosis reveals nucleosome shifting on mitotically silenced genes. Mol Cell (2010) 1.85
Bisulfite sequencing of chromatin immunoprecipitated DNA (BisChIP-seq) directly informs methylation status of histone-modified DNA. Genome Res (2012) 1.78
A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression. PLoS Genet (2011) 1.60
DNA demethylation and pericentromeric rearrangements of chromosome 1. Mutat Res (1997) 1.60
Nucleosomes containing methylated DNA stabilize DNA methyltransferases 3A/3B and ensure faithful epigenetic inheritance. PLoS Genet (2011) 1.56
Enhancer identification through comparative genomics. Semin Cell Dev Biol (2007) 1.56
OCT4 establishes and maintains nucleosome-depleted regions that provide additional layers of epigenetic regulation of its target genes. Proc Natl Acad Sci U S A (2011) 1.51
Dynamic nucleosome-depleted regions at androgen receptor enhancers in the absence of ligand in prostate cancer cells. Mol Cell Biol (2011) 1.34
Active PHO5 chromatin encompasses variable numbers of nucleosomes at individual promoters. Nat Struct Mol Biol (2006) 1.29
DNA methylation and cancer. Prog Drug Res (2011) 1.24
Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning. Hum Mol Genet (2009) 1.20
Distinct properties of cell-type-specific and shared transcription factor binding sites. Mol Cell (2013) 1.16
Cloning, characterization and expression of the gene coding for a cytosine-5-DNA methyltransferase recognizing GpC. Nucleic Acids Res (1998) 1.14
Nucleosomes protect DNA from DNA methylation in vivo and in vitro. Nucleic Acids Res (2011) 1.08
Single-molecule and population probing of chromatin structure using DNA methyltransferases. Methods (2007) 1.02
Effects of DNA methylation on nucleosome stability. Nucleic Acids Res (2013) 0.99
Nucleosome and transcription activator antagonism at human beta-globin locus control region DNase I hypersensitive sites. Nucleic Acids Res (2007) 0.99
Hypomethylation of classical satellite DNA and chromosome instability in lymphoblastoid cell lines. Hum Genet (1993) 0.99
Mapping chromatin structure in vivo using DNA methyltransferases. Methods (2004) 0.98
SNF5 is an essential executor of epigenetic regulation during differentiation. PLoS Genet (2013) 0.87
DNA methyltransferase probing of DNA-protein interactions. Methods Mol Biol (2006) 0.82
Transcriptional and epigenetic regulation of the GM-CSF promoter by RUNX1. Leuk Res (2010) 0.79
Role of nucleosomes in mitotic bookmarking. Cell Cycle (2011) 0.79